0.6(top 50%)
impact factor
990(top 20%)
papers
47.0K(top 10%)
citations
90(top 5%)
h-index
0.6(top 50%)
impact factor
1.1K
all documents
48.1K
doc citations
176(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Pharmacodynamics19872,111
2Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Pharmacodynamics19781,879
3Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Pharmacodynamics19811,419
4Statistical moments in pharmacokineticsJournal of Pharmacokinetics and Pharmacodynamics19781,161
5Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Pharmacodynamics1993699
6Statistical estimations in pharmacokineticsJournal of Pharmacokinetics and Pharmacodynamics1974681
7Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Pharmacodynamics1973674
8Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Pharmacodynamics1977673
9Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Pharmacodynamics1977596
10Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokineticsJournal of Pharmacokinetics and Pharmacodynamics1982570
11Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Pharmacodynamics1978567
12The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Pharmacodynamics1980529
13Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Pharmacodynamics1980455
14Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Pharmacodynamics1992442
15Measuring the predictive performance of computer-controlled infusion pumpsJournal of Pharmacokinetics and Pharmacodynamics1992438
16The importance of modeling interoccasion variability in population pharmacokinetic analysesJournal of Pharmacokinetics and Pharmacodynamics1993409
17A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximationJournal of Pharmacokinetics and Pharmacodynamics1978387
18Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patientsJournal of Pharmacokinetics and Pharmacodynamics1976342
19Animal scale-upJournal of Pharmacokinetics and Pharmacodynamics1973339
20Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the dataJournal of Pharmacokinetics and Pharmacodynamics1976334
21Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoinJournal of Pharmacokinetics and Pharmacodynamics1980318
22Optimal sampling times for pharmacokinetic experimentsJournal of Pharmacokinetics and Pharmacodynamics1981297
23Influence of food and diet on gastrointestinal drug absorption: A reviewJournal of Pharmacokinetics and Pharmacodynamics1977291
24Testing for the equality of area under the curves when using destructive measurement techniquesJournal of Pharmacokinetics and Pharmacodynamics1988289
25Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humansJournal of Pharmacokinetics and Pharmacodynamics1996267
26Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Pharmacodynamics1983257
27Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selectionJournal of Pharmacokinetics and Pharmacodynamics1994254
28Evaluation of methods for estimating population pharmacokinetic parameters II. Biexponential model and experimental pharmacokinetic dataJournal of Pharmacokinetics and Pharmacodynamics1981250
29Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)Journal of Pharmacokinetics and Pharmacodynamics1992234
30A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validationJournal of Pharmacokinetics and Pharmacodynamics1996229
31A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerationsJournal of Pharmacokinetics and Pharmacodynamics1986227
32Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pumpJournal of Pharmacokinetics and Pharmacodynamics1992223
33Consideration of individual bioequivalenceJournal of Pharmacokinetics and Pharmacodynamics1990216
34Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFITJournal of Pharmacokinetics and Pharmacodynamics1977210
35Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutritionJournal of Pharmacokinetics and Pharmacodynamics1993206
36Overview of enzymes of drug metabolismJournal of Pharmacokinetics and Pharmacodynamics1996195
37Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Pharmacodynamics1977192
38Pharmacokinetic studies on the selectiveβ 1-receptor antagonist metoprolol in manJournal of Pharmacokinetics and Pharmacodynamics1974183
39The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenonJournal of Pharmacokinetics and Pharmacodynamics1987183
40Kinetics of drug-drug interactionsJournal of Pharmacokinetics and Pharmacodynamics1973179
41A review of the applications of physiologically based pharmacokinetic modelingJournal of Pharmacokinetics and Pharmacodynamics1979175
42Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjectsJournal of Pharmacokinetics and Pharmacodynamics1977166
43A new statistical procedure for testing equivalence in two-group comparative bioavailability trialsJournal of Pharmacokinetics and Pharmacodynamics1984166
44Pharmacokinetics of isoniazid metabolism in manJournal of Pharmacokinetics and Pharmacodynamics1976165
45Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolismJournal of Pharmacokinetics and Pharmacodynamics1983163
46Dose dependent pharmacokinetics of prednisone and prednisolone in manJournal of Pharmacokinetics and Pharmacodynamics1981160
47A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolamJournal of Pharmacokinetics and Pharmacodynamics1991157
48Pharmacokinetics in the aged: A reviewJournal of Pharmacokinetics and Pharmacodynamics1975155
49Physiologic modeling of cyclosporin kinetics in rat and manJournal of Pharmacokinetics and Pharmacodynamics1991155
50A critical evaluation of the principles governing the advantages of intra-arterial infusionsJournal of Pharmacokinetics and Pharmacodynamics1974153